I love how this stock isn't heavily traded and talked about on HC, it avoids manipulation and day trader attention. At approx 40mil MC and results from 2 phase II's due first half this year, with the lupus trial interim results potentially due any day now, and a share register of less than half a million, this is a great buy. Has anyone checked out how BLT is going lately, with a MC of over 50mil, and they have only one phase II trial I think, granted they have an extensive pipeline of pre-clinicals.
The low liquidity should provide a skyrocketing share price upon release of positive interim lupus results IMO.
Any Chartists care to comment on this downtrend and if it looks like breaking? I'm unsure if the recent touch of 7.8 was the bottom, but there seems to be some decent support around the mid 8's-9
IVX Price at posting:
8.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)